ONESOURCE SPECL PHARMA L Share Price

ONESOURCE SPECL PHARMA L Share Price

NSE: ONESOURCE
|
Pharmaceuticals
|
S Cap
₹ 1,596.70
+₹8.80 (0.55%)
1D
Last updated 23 Sep, 2026, 15:57 IST

ONESOURCE SPECL PHARMA L Share Price Today

As of 23 Sep 2026, ONESOURCE SPECL PHARMA L share price is ₹1,596.70. The stock opened at ₹1,595.00, compared to its previous close of ₹1,587.90. During today's trading session, ONESOURCE SPECL PHARMA L share price moved in the range of ₹1,587.90 to ₹1,609.50, with an average price of ₹1,598.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,057.00 and a high of ₹1,925.00. On the performance front, ONESOURCE SPECL PHARMA L share price has increased by 9.03% over the last six months and is down 11.88% on a year-on-year basis.

₹1,587.90
0.55% up today
₹1,609.50
1D LOW
1D HIGH

ONESOURCE SPECL PHARMA L Returns Calculator

Circuit
L
H
₹1,270.40
₹1,905.40
52-week
L
H
₹1,057.00
₹1,925.00

About ONESOURCE SPECL PHARMA L

ONESOURCE SPECL PHARMA L Share Price
ISIN
INE013P01021
Sector Market Cap
₹ 18,203.75 Cr

OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

ONESOURCE SPECL PHARMA L Financial Highlights

  • Revenue: ONESOURCE SPECL PHARMA L reported revenue of ₹1,436.61 crore in FY26 vs ₹1,462.32 crore in FY25. It showed a decrease of 1.76% on a yearly basis.
  • Operating Profit: ONESOURCE SPECL PHARMA L reported an operating loss of ₹91.96 crore in FY26 vs ₹67.07 crore in FY25. It showed a decrease of 37.11% on a year-on-year basis.
  • Net Profit: ONESOURCE SPECL PHARMA L reported a net loss of ₹73.80 crore in FY26 vs ₹17.97 crore in FY25. It showed a decrease of 310.68% on a yearly basis.

ONESOURCE SPECL PHARMA L Quarterly Result Highlights

  • ONESOURCE SPECL PHARMA L reported revenue of ₹452.82 crore in Jun 2026, compared with ₹430.31 crore in Mar 2026, representing an increase of 5.23% on a quarter-on-quarter (QoQ) basis.
  • ONESOURCE SPECL PHARMA L reported an operating profit of ₹20.29 crore in Jun 2026, compared with ₹0.29 crore in Mar 2026, representing an increase of 7,096.55% on a quarter-on-quarter (QoQ) basis.
  • ONESOURCE SPECL PHARMA L reported a profit of ₹25.00 crore in Jun 2026, compared with ₹4.60 crore in Mar 2026, reflecting an increase of 443.48% on a QoQ basis.
  • The earnings per share (EPS) of ONESOURCE SPECL PHARMA L stood at ₹6.44 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
30.48%
FII
19.19%
Other DII
10.40%
Retail and other
26.95%
Mutual funds
12.98%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202519.39%
Dec 202519.24%
Mar 202617.50%
Jun 202619.19%
Mkt Cap Cr
18,203.80
P/E
-374.40
P/B
3.12
ROE
-1.10%
D/E
0.25
ROCE
0.55%
Div. Yield
0.00%
EPS(TTM)
1.85
Turnover
0.18
EV/EBITDA
57.19
Net Margin
1.89%
Op. Margin
20.20%
ROA
-0.59%
Quick Ratio
0.67
Curr. Ratio
1.82
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
OneSource Speci. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
OneSource Speci. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
OneSource Speci. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ONESOURCE SPECL PHARMA L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,421.59₹1,444.85₹171.92₹38.71
Other Income₹15.02₹17.47₹4.23₹2.69
Total Revenue₹1,436.61₹1,462.33₹176.14₹41.41
Total Expenses₹1,518.65₹1,418.55₹425.90₹312.63
Profit Before Tax-₹91.96-₹67.07-₹365.70-₹415.65
Tax-₹18.16-₹49.79₹0.00₹0.00
Profit After Tax-₹73.80-₹17.28-₹365.70-₹415.65
EPS - Basic-₹6.44-₹1.63-₹94.15-₹200.87
EPS - Diluted-₹6.44-₹1.63-₹94.15-₹200.87

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹91.96-₹67.76-₹391.17-₹799.83
Income before WC changes₹293.80₹359.04-₹103.08-₹195.51
Change in Assets-₹457.50-₹287.99-₹77.49-₹36.86
Change in Liabilities₹180.92-₹131.89₹73.36₹58.56
Change in WC-₹276.57-₹419.89-₹4.13₹21.70
Cash flow from Operations₹8.52-₹67.85-₹107.21-₹162.88
Cash flow from Investing-₹494.98-₹201.08₹510.55-₹67.72
Cash flow from Financing₹359.44₹412.01-₹390.54₹118.32
Total Cash Flow-₹127.02₹143.07₹12.79-₹112.28
Cash (Start of the year)₹165.36₹22.26₹9.47₹121.76
Cash (End of the year)₹38.34₹165.36₹22.26₹9.47

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹6,784.07₹6,464.06₹1,132.23₹1,780.40
Current Assets₹1,425.94₹1,086.18₹176.38₹228.40
Total Assets₹8,210.01₹7,550.24₹1,308.61₹2,008.81
Current Liabilities₹1,441.97₹1,113.56₹630.59₹865.22
Net Current Asset-₹16.03-₹27.38-₹454.21-₹636.81
Non-Current Liabilities₹936.76₹556.10₹282.31₹358.14
Equity Capital₹5,831.29₹5,880.58₹395.71₹785.45
Total Equity & Liabilities₹8,210.01₹7,550.24₹1,308.61₹2,008.81

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,405.38₹1,299.59₹171.92₹38.71
Other Income₹15.01₹17.68₹4.23₹2.70
Total Revenue₹1,420.39₹1,317.27₹176.14₹41.42
Total Expenses₹1,393.76₹1,226.48₹425.14₹312.56
Profit Before Tax₹21.21-₹21.46-₹364.93-₹429.55
Tax₹0.00-₹41.46₹0.00₹0.00
Profit After Tax₹21.21₹20.00-₹364.93-₹429.55
EPS - Basic₹1.85₹1.75-₹93.97-₹200.69
EPS - Diluted₹1.85₹1.75-₹93.97-₹200.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹21.21-₹22.15-₹390.40-₹799.11
Income before WC changes₹260.42₹262.52-₹102.33-₹194.18
Change in Assets-₹489.26-₹303.13-₹79.79-₹37.15
Change in Liabilities₹280.68₹0.23₹73.13₹55.70
Change in WC-₹208.58-₹302.90-₹6.66₹18.55
Cash flow from Operations₹55.18-₹47.28-₹108.99-₹164.70
Cash flow from Investing-₹477.60-₹300.04₹505.99-₹65.68
Cash flow from Financing₹361.06₹417.22-₹384.22₹118.32
Total Cash Flow-₹61.37₹69.90₹12.78-₹112.06
Cash (Start of the year)₹92.09₹22.19₹9.41₹121.47
Cash (End of the year)₹30.72₹92.09₹22.19₹9.41

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹6,819.03₹6,366.58₹1,132.16₹1,780.23
Current Assets₹1,457.03₹1,023.88₹176.42₹228.21
Total Assets₹8,276.06₹7,390.46₹1,308.58₹2,008.44
Current Liabilities₹1,523.93₹1,069.48₹628.52₹863.59
Net Current Asset-₹66.90-₹45.60-₹452.10-₹635.38
Non-Current Liabilities₹801.91₹400.88₹282.31₹358.14
Equity Capital₹5,950.22₹5,920.10₹397.74₹786.71
Total Equity & Liabilities₹8,276.06₹7,390.46₹1,308.58₹2,008.44
* All values are in INR Crore
Qty
Bid
17
1596.7
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 17
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.28
Neutral
ATR (14)
62.72
Neutral
STOCH(9,6)
52.78
Neutral
STOCH RSI (14)
73.42
Neutral
ADX(9)
26.58
Bearish
UO(9)
36.76
Neutral
ROC(12)
0.77
Bullish
WillR(14)
-46.87
Neutral
Period
Simple value
Exponential vaue
5D
1591.72
1589.43
10D
1580.19
1580.68
20D
1555.43
1571.12
50D
1586.92
1584.25
100D
1655.23
1599.77
Volume trend — traded volume by day
23 Sep1L
22 Sep1L
21 Sep3L
18 Sep3L
17 Sep1L
16 Sep1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ONESOURCE SPECL PHARMA L Share Price
ONESOURCE SPECL PHARMA L
Pharmaceuticals
Add Stock
Add Another

ONESOURCE SPECL PHARMA L Share Price FAQs

ONESOURCE SPECL PHARMA L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837